ReviewJournal of cancer research and clinical oncology2024

Opportunities and challenges of using circulating tumor DNA to predict lung cancer immunotherapy efficacy.

Shanshan Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.